We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.86%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$49.2B
AUM Growth
-$3.11B
Cap. Flow
-$91.1M
Cap. Flow %
-0.19%
Top 10 Hldgs %
25.77%
Holding
2,288
New
88
Increased
463
Reduced
591
Closed
79

Sector Composition

Rank Sector Weight
1 Technology 22.61%
2 Healthcare 15.91%
3 Financials 13.97%
4 Consumer Discretionary 9.85%
5 Industrials 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBSI icon
1726
Southside Bancshares
SBSI
$974M
$321K ﹤0.01%
7,860
KPTI icon
1727
Karyopharm Therapeutics
KPTI
$161M
$320K ﹤0.01%
2,892
BEKE icon
1728
KE Holdings
BEKE
$17.6B
$319K ﹤0.01%
25,800
USNA icon
1729
Usana Health Sciences
USNA
$429M
$318K ﹤0.01%
4,000
GSHD icon
1730
Goosehead Insurance
GSHD
$1.64B
$317K ﹤0.01%
4,040
HVT icon
1731
Haverty Furniture Companies
HVT
$421M
$317K ﹤0.01%
11,550
BMEA icon
1732
Biomea Fusion
BMEA
$90.4M
$312K ﹤0.01%
70,000
RCUS icon
1733
Arcus Biosciences
RCUS
$3.4B
$312K ﹤0.01%
9,880
VERA icon
1734
Vera Therapeutics
VERA
$2.39B
$312K ﹤0.01%
+13,277
New +$286K
LPRO
1735
Open Lending Corp
LPRO
$373M
$311K ﹤0.01%
16,450
RKLB icon
1736
Rocket Lab Corp
RKLB
$39.9B
$310K ﹤0.01%
38,560
+31,000
+410% +$288K
XFOR icon
1737
X4 Pharmaceuticals
XFOR
$371M
$309K ﹤0.01%
5,884
SGRY icon
1738
Surgery Partners
SGRY
$2.04B
$308K ﹤0.01%
5,600
AROC icon
1739
Archrock
AROC
$6.19B
$307K ﹤0.01%
33,210
+21,710
+189% +$186K
RVMD icon
1740
Revolution Medicines
RVMD
$39.1B
$306K ﹤0.01%
11,990
+840
+8% +$18.3K
AMWL icon
1741
American Well
AMWL
$185M
$305K ﹤0.01%
3,617
-5,448
-60% -$460K
DOMO icon
1742
Domo
DOMO
$177M
$305K ﹤0.01%
6,040
OWL icon
1743
Blue Owl Capital
OWL
$6.63B
$305K ﹤0.01%
+24,030
New +$304K
CALX icon
1744
Calix
CALX
$2.34B
$304K ﹤0.01%
7,090
ELDN icon
1745
Eledon Pharmaceuticals
ELDN
$262M
$304K ﹤0.01%
77,100
ESLT icon
1746
Elbit Systems
ESLT
$38.4B
$304K ﹤0.01%
1,350
PPC icon
1747
Pilgrim's Pride
PPC
$7.09B
$304K ﹤0.01%
12,100
BILI icon
1748
Bilibili
BILI
$7.56B
$303K ﹤0.01%
11,850
ICHR icon
1749
Ichor Holdings
ICHR
$2.37B
$303K ﹤0.01%
8,500
INGN icon
1750
Inogen
INGN
$174M
$302K ﹤0.01%
9,315

Similar funds

Ensign Peak Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Ensign Peak Advisors held 2,288 positions worth $49.2B, down 5.9% from $52.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ensign Peak Advisors's Q1 2022 filing shows 88 new, 463 increased, 591 reduced and 79 closed positions. Its largest new stake was Constellation Energy: 260,204 shares worth $14.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $105M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q1 2022 buy was Constellation Energy: 260,204 shares worth $14.6M.
  • Ensign Peak Advisors added most to iShares Russell 2000 ETF in Q1 2022, an estimated $261M increase.
  • Ensign Peak Advisors's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Ensign Peak Advisors fully exited Athene Holding Ltd. Class A Common Shares in Q1 2022, selling an estimated $64.3M.
  • Ensign Peak Advisors's ten largest holdings make up 26% of its $49.2B portfolio in Q1 2022.
  • Ensign Peak Advisors opened 88 new positions and closed 79 in Q1 2022.
  • Ensign Peak Advisors's portfolio value fell 5.9% quarter-over-quarter to $49.2B.

Based on Ensign Peak Advisors's 13F filing for Q1 2022, filed 16 May 2022.